Actively Recruiting

Phase Not Applicable
Age: 18Years +
All Genders
ID05759065

A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care

Led by Brigham and Women's Hospital · Updated on 2026-05-07

350

Participants Needed

1

Research Sites

N/A

Total Duration

On this page

AI-Summary

What this Trial Is About

Researchers are evaluating two types of behavioral treatments for insomnia among socioeconomically disadvantaged adults in primary care. The study aims to test whether tele-Brief Behavioral Treatment for Insomnia (BBTI) is not less effective than tele-Cognitive-Behavioral Therapy for Insomnia (CBTI). The trial focuses on adults diagnosed with insomnia, particularly those facing socioeconomic challenges, to find accessible treatment options. The study compares two telehealth interventions: BBTI, which involves up to five weekly phone sessions delivered by various practitioners without formal sleep training, and CBTI, a more comprehensive therapy conducted by trained mental health clinicians over 6 to 12 weeks. Participants are randomly assigned to one of these two groups to receive the respective treatment remotely. Participants will be monitored over several months, with primary outcomes measured by the Insomnia Severity Index at 3 months. Secondary outcomes include insomnia severity at 6 and 12 months, quality of life assessments, anxiety and depression measures, sleep impairment and disturbance scales, sleep diary reports, and hypnotic medication use. The study tracks these outcomes through patient-reported questionnaires and sleep diaries to evaluate treatment effects and overall health impact.

CONDITIONS

Brief Title

A Hybrid Effectiveness Implementation Trial Evaluating Behavioral Treatments for Insomnia for Socioeconomically Disadvantaged Adults in Primary Care

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Aged 18 years or older
  • Meet clinical diagnostic criteria for insomnia (DSM-V criteria)
  • Insomnia severity score greater than 10
  • Eligible to receive care through publicly-supported medical assistance or identify as racial or ethnic minority
  • Has capacity for informed consent (SDT<9)
Not Eligible

You will not qualify if you...

  • Untreated, current major depressive disorder (PHQ-8 ≥ 20)
  • History of bipolar disorder or psychosis
  • Active alcohol or drug abuse
  • Excessive daytime sleepiness (Epworth Sleepiness Scale score ≥ 16)
  • Seizure within the past 1 year
  • Main sleep period outside of 8pm - 11am
  • Regular night shift work (5 overnight shifts/month between midnight-5am)
  • Untreated moderate to severe sleep apnea
  • Severe medical condition requiring possible hospitalization in next 6 months
  • Active suicidal ideation during screening
  • Pregnant or planning to become pregnant
  • Participation in other studies affecting intervention benefit or safety as determined by the study PI

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

screening and enrollment visit

Outpatient Treatment

Duration - Up to 12 weeks depending on treatment assignment

Participants receive one of two behavioral treatments for insomnia delivered remotely by phone over several weeks.

Weekly visits by phone for up to 5 or 6 to 12 weeks depending on treatment

Follow-up

Duration - Up to 12 months

Participants are monitored to assess the effects of treatment on insomnia severity and quality of life.

Assessments at 3, 6, and 12 months after treatment start

Trial Site Locations

Total: 1 location

1

Brigham and Women's Hospital

Boston, Massachusetts, United States, 02115

Actively Recruiting

Loading map...

Research Team

S

Suzanne Bertisch, MD, MPH

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here